Yeungnam Univ J Med.  2018 Jun;35(1):27-35. 10.12701/yujm.2018.35.1.27.

Diabetes and depression

Affiliations
  • 1Department of Internal Medicine, Catholic University of Daegu, School of Medicine, Daegu, Korea. ejjeon@cu.ac.kr

Abstract

Diabetes and depression are serious chronic conditions. As a result of their increasing prevalence, diabetes and depression, together with population growth and aging, are public health issues. The rate of depression in adults with either type 1 diabetes or type 2 diabetes is high relative to the general population. The coexistence of diabetes and depression has attracted much interest. Although it is unclear whether diabetes and depression are causally linked, most studies have shown that the association between diabetes and depression might be bidirectional. Currently, emotional well-being is becoming an increasingly important aspect of diabetes care and self-management. Psychiatric disorders and diabetic distress among people with diabetes may increase the risk of diabetes complication and mortality. Thus, assessment and appropriate management of depression in people with diabetes should be considered to achieve psychological well-being and optimize medical outcomes.

Keyword

Depression; Diabetes; Mental Health

MeSH Terms

Adult
Aging
Depression*
Diabetes Complications
Humans
Mental Health
Mortality
Population Growth
Prevalence
Public Health
Self Care

Figure

  • Fig. 1. Hypothesis of biological mechanisms of diabetes and depression. HPA, hypothalamus-pituitary-adrenal.


Cited by  1 articles

Depressive Disorder and Diabetes
Eonju Jeon
J Korean Diabetes. 2022;23(3):178-184.    doi: 10.4093/jkd.2022.23.3.178.


Reference

1. International Diabetes Federation. IDF diabetes atlas. 8th ed. Brussels: International Diabetes Federation;2017.
2. World Health Organization. Depression and other common. mental disorders: global health estimates. Geneva: World Health Organization;2017.
3. Korean Diabetes Association. Diabetes fact sheet in Korea 2016 [Internet]. Seoul: Korean Diabetes Association;2017. [cited 2018 April 18]. http://www.diabetes.or.kr/temp/KDA_fact_sheet%202016.pdf.
4. Tabák AG, Akbaraly TN, Batty GD, Kivimäki M. Depression and type 2 diabetes: a causal association? Lancet Diabetes Endocrinol. 2014; 2:236–45.
Article
5. Katon WJ. The comorbidity of diabetes mellitus and depression. Am J Med. 2008; 121(11 Suppl 2):S8–15.
Article
6. IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med. 2006; 23:579–93.
7. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder. 3rd ed. Arlington: International Diabetes Federation;2010.
8. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee; Ekoé JM, Punthakee Z, Ransom T, Prebtani AP, Goldenberg R. Screening for type 1 and type 2 diabetes. Can J Diabetes. 2013; 37(Suppl 1):S12–5.
9. Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: a position statement of the American Diabetes Association. Diabetes Care. 2016; 39:2126–40.
Article
10. Kahn CR, Weir GC, King GL, Moses AC, Smith RJ, Jacobson AM. Joslin’s diabetes mellitus. 14th ed. Philadelphia: Lippincott Williams & Willkins;2005.
11. Dejgaard A, Gade A, Larsson H, Balle V, Parving A, Parving HH. Evidence for diabetic encephalopathy. Diabet Med. 1991; 8:162–7.
Article
12. Jesulola E, Micalos P, Baguley IJ. Understanding the pathophysiology of depression: from monoamines to the neurogenesis hypothesis model - are we there yet? Behav Brain Res. 2018; 341:79–90.
Article
13. Nagy G, Ronai Z, Somogyi A, Sasvari-Szekely M, Rahman OA, Mate A, et al. P2RX7 Gln460Arg polymorphism is associated with depression among diabetic patients. Prog Neuropsychopharmacol Biol Psychiatry. 2008; 32:1884–8.
Article
14. Moulton CD, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015; 3:461–71.
Article
15. World Health Organization. Pharmacological treatment of mental disorders in primary health care. Geneva: World Health Organization;2009.
16. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington: American Psychiatric Association;2013.
17. Willis T. Diabetes; a medical odyssey. Tuckahoe: USV Pharmaceutical Corp;1971.
18. Renn BN, Feliciano L, Segal DL. The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev. 2011; 31:1239–46.
Article
19. Grey M, Cameron ME, Lipman TH, Thurber FW. Psychosocial status of children with diabetes in the first 2 years after diagnosis. Diabetes Care. 1995; 18:1330–6.
Article
20. Winkley K, Ismail K, Landau S, Eisler I. Psychological interventions to improve glycaemic control in patients with type 1 diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ. 2006; 333:65.
Article
21. Bennett DS. Depression among children with chronic medical problems: a meta-analysis. J Pediatr Psychol. 1994; 19:149–69.
Article
22. Moulton CD, Costafreda SG, Horton P, Ismail K, Fu CH. Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes. Brain Imaging Behav. 2015; 9:651–62.
Article
23. Korczak DJ, Pereira S, Koulajian K, Matejcek A, Giacca A. Type 1 diabetes mellitus and major depressive disorder: evidence for a biological link. Diabetologia. 2011; 54:2483–93.
Article
24. Lyoo IK, Yoon SJ, Musen G, Simonson DC, Weinger K, Bolo N, et al. Altered prefrontal glutamate-glutamine-gamma-aminobutyric acid levels and relation to low cognitive performance and depressive symptoms in type 1 diabetes mellitus. Arch Gen Psychiatry. 2009; 66:878–87.
Article
25. Lyoo IK, Yoon S, Jacobson AM, Hwang J, Musen G, Kim JE, et al. Prefrontal cortical deficits in type 1 diabetes mellitus: brain correlates of comorbid depression. Arch Gen Psychiatry. 2012; 69:1267–76.
Article
26. Bolo NR, Musen G, Simonson DC, Nickerson LD, Flores VL, Siracusa T, et al. Functional connectivity of insula, basal ganglia, and prefrontal executive control networks during hypoglycemia in type 1 diabetes. J Neurosci. 2015; 35:11012–23.
Article
27. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes. Results of 5-yr follow-up study. Diabetes Care. 1988; 11:605–12.
Article
28. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996; 19:1097–102.
Article
29. Lee HS, Lee JS, Lee HP, Jeon CE. Diabetes, Depression and doctor-patient relationship. Korean Diabetes J. 2009; 33:178–82. Korean.
Article
30. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008; 455:894–902.
Article
31. Knol MJ, Twisk JW, Beekman AT, Heine RJ, Snoek FJ, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus:a meta-analysis. Diabetologia. 2006; 49:837–45.
32. Maes M. Cytokines in major depression. Biol Psychiatry. 1994; 36:498–9.
Article
33. Pickup JC. Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes. Diabetes Care. 2004; 27:813–23.
Article
34. Germain A, Kupfer DJ. Circadian rhythm disturbances in depression. Hum Psychopharmacol. 2008; 23:571–85.
Article
35. Reutrakul S, Van Cauter E. Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes. Ann N Y Acad Sci. 2014; 1311:151–73.
Article
36. Kan C, Pedersen NL, Christensen K, Bornstein SR, Licinio J, MacCabe JH, et al. Genetic overlap between type 2 diabetes and depression in Swedish and Danish twin registries. Mol Psychiatry. 2016; 21:903–9.
Article
37. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care. 2001; 24:1069–78.
38. Beck AT, Steer RA, Brown GK. BDI-II, beck depression inventory: manual. 2nd ed. San Antonio: Psychological Corp;Boston: Harcourt Brace;1996.
39. Zauszniewski JA, Chung C, Krafcik K, Sousa VD. Psychometric testing of the depressive cognition scale in women with type 2 diabetes. J Nurs Meas. 2001; 9:61–72.
Article
40. Colón de Martí LN, Guzmán Yunqué FS, Guevara-Ramos LM. Early detection of depression using the Zung Self-Rating Depression Scale. P R Health Sci J. 1997; 16:375–9.
41. Fisher L, Chesla CA, Mullan JT, Skaff MM, Kanter RA. Contributors to depression in Latino and European-American patients with type 2 diabetes. Diabetes Care. 2001; 24:1751–7.
Article
42. Marathe PH, Gao HX, Close KL. American Diabetes Association Standards of Medical Care in Diabetes 2017. J Diabetes. 2017; 9:320–4.
Article
43. Jones A, Vallis M, Pouwer F. If it does not significantly change HbA1c levels why should we waste time on it? A plea for the prioritization of psychological well-being in people with diabetes. Diabet Med. 2015; 32:155–63.
44. Deborah YH, Mark P. Psychosocial care for people with diabetes. Alexandria: American Diabetes Association;2012. p. 240.
45. Lim SY, Lee EJ, Jeong SW, Kim HC, Jeong CH, Jeon TY, et al. The validation study of Beck Depression Scale 2 in Korean version. Anxiety Mood. 2011; 7:48–53.
46. Spitzer RL, Williams JB, Kroenke K, Linzer M, deGruy FV 3rd, Hahn SR, et al. Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA. 1994; 272:1749–56.
Article
47. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002; 32:509–15.
Article
48. Shin JH, Kim HC, Jung CH, Kim JB, Jung SW, Cho HJ, et al. The Standardization of the Korean Version of the Patient Health Questionnaire-2. J Korean Neuropsychiatr Assoc. 2013; 52:115–21. Korean.
Article
49. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4:561–71.
Article
50. Yoon SY, Lim JH, Han C. Rating scales for measurementbased clinical practice of depression. Korean J Psychopharmacol. 2012; 23:136–46. Korean.
51. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982-. 1983; 17:37–49.
Article
52. Sheikh JI, Yesavage JA. Geriatric Depression Scale (GDS): recent evidence and development of a shorter version. In : Brink TL, editor. Clinical gerontology: a guide to assessment and intervention. New York: The Haworth Press;1986. p. 165–73.
53. Bae JN, Cho MJ. Development of the Korean version of the Geriatric Depression Scale and its short form among elderly psychiatric patients. J Psychosom Res. 2004; 57:297–305.
Article
54. Montorio I, Izal M. The Geriatric Depression Scale: a review of its development and utility. Int Psychogeriatr. 1996; 8:103–12.
Article
55. World Health Organization. ICD-10 Version: 2016 [Internet]. Geneva: World Health Organization;2017. [cited 2018 April 18]. http://apps.who.int/classifications/icd10/browse/2016/en.
56. Kwon JS, Kee NK, Bahk WM, Shin MS, Yu BH, et al. Diagnostic and statistical manual of mental disorders DSM. 5th ed. Seoul: Hakjisa;2015.
57. Saito M, Iwata N, Kawakami N, Matsuyama Y, Ono Y, Nakane Y, et al. Evaluation of the DSM-IV and ICD-10 criteria for depressive disorders in a community population in Japan using item response theory. Int J Methods Psychiatr Res. 2010; 19:211–22.
Article
58. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clouse RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care. 2000; 23:934–42.
Article
59. Gonzalez JS, Safren SA, Cagliero E, Wexler DJ, Delahanty L, Wittenberg E, et al. Depression, self-care, and medication adherence in type 2 diabetes: relationships across the full range of symptom severity. Diabetes Care. 2007; 30:2222–7.
60. Gonzalez JS, Peyrot M, McCarl LA, Collins EM, Serpa L, Mimiaga MJ, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008; 31:2398–403.
Article
61. Park HS, Hong YS, Lee HJ, Ha EH, Sung YA. The association between depressive symptoms and glycemic control in the patients with diabetes mellitus. Korean J Med. 2003; 64:204–10. Korean.
62. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med. 2001; 63:619–30.
Article
63. Lin EH, Rutter CM, Katon W, Heckbert SR, Ciechanowski P, Oliver MM, et al. Depression and advanced complications of diabetes: a prospective cohort study. Diabetes Care. 2010; 33:264–9.
64. Egede LE, Nietert PJ, Zheng D. Depression and all-cause and coronary heart disease mortality among adults with and without diabetes. Diabetes Care. 2005; 28:1339–45.
Article
65. Zhang X, Norris SL, Gregg EW, Cheng YJ, Beckles G, Kahn HS. Depressive symptoms and mortality among persons with and without diabetes. Am J Epidemiol. 2005; 161:652–60.
Article
66. Kovacs M. Children’s depression inventory (CDI2): technical manual. North Tonawanda: Multi-Health Systems;2011.
Full Text Links
  • YUJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr